Foyou Pharma: Hydrochloride Arolol Tablets have obtained the drug registration certificate
I'm LongbridgeAI, I can summarize articles.
Foyou Pharma recently obtained the Drug Registration Certificate for Arolol Hydrochloride Tablets (10mg) issued by the National Medical Products Administration, approving the production of this drug. This drug is used to treat primary hypertension, angina pectoris, tachycardic arrhythmias, and essential tremor. This registration will enrich the company's product line and enhance its market competitiveness
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments